Oliver Kepp
  • E-mail :[email]
  • Phone : +33 1 42 11 45 16
  • Location : Paris, France
Last update 2021-03-19 17:18:59.988

Oliver Kepp PhD; HDR

Course and current status

Since 2019 Cofounder Samsara Therapeutics, Delaware, US

Since 2013 Direktor Cell Biology platform, Gustave Roussy Cancer Center, Villejuif, France

Since 2012 CR1, INSERM U1138 (Kroemerlab), Centre de Recherche Des Cordeliers, Paris, France

2010-2011 INSERM PostDoctoral fellow, Gustave Roussy Cancer Center, Villejuif, France

2008-2010 EMBO fellow, INSERM U848 (Kroemerlab), Gustave Roussy Cancer Center, Villejuif, France

2007 Max Planck PostDoctoral fellow, Max Planck Insitute for Infection Biology, Berlin, Germany

Until 2006 PhD Max Planck Insitute for Infection Biology, Humboldt University, Berlin, Germany

Scientific summary

Dr. Oliver Kepp graduated from Humboldt University Berlin and obtained a PhD degree in Molecular Biology for his work on "Host cell apoptosis" conducted at the Max Planck Institute for Infection Biology. Following he was a Max Planck postdoctoral research fellow and in 2007 joined the INSERM team directed by Prof. Guido Kroemer at the Gustave Roussy Cancer Center (GRCC) as an EMBO postdoc fellow. He now is a tenured researcher at INSERM and a Co-director of the BioCell automation platform at GRCC. In his work he investigates several aspects of immunogenic cell death, focusing on systems biology approaches. Oliver published more than 270 scientific articles, is a member of several editorial boards, a co-founder of Samsara therapeutics and has recently been appointed associated director of the European academy of tumor immunology. Oliver received the prestigious Clarivate Highly Cited Researcher Award three years in a row since 2018.

Image d’exemple